Todas as fotos(1)

Documentos Principais

Y0001416

Betamethasone dipropionate for peak identification

Name: Betamethasone dipropionate for peak identification
Brand: SIAL

European Pharmacopoeia (EP) Reference Standard

Sinônimo(s):

Betamethasone 17,21-dipropionate, 9α-Fluoro-16β-methyl-11β,17α,21-trihydroxy-1,4-pregnadiene-3,20-dione 17,21-dipropionate

Faça loginpara ver os preços organizacionais e de contrato

Todas as fotos(1)

About This Item

Fórmula empírica (Notação de Hill):

C₂₈H₃₇FO₇

Número CAS:

5593-20-4

Peso molecular:

504.59

Número MDL:

MFCD00133140

Código UNSPSC:

41116107

ID de substância PubChem:

329831413

NACRES:

NA.24

Produtos recomendados

Slide 1 of 10

1 of 10

Y0000641

Azithromycin for system suitability

B1040000

Betamethasone dipropionate

Y0000637

Azithromycin for peak identification

Y0000307

Azithromycin impurity A

Y0001925

Betamethasone dipropionate for system suitability A

M2900000

Mometasone furoate

Supelco

PHR1619

Beclomethasone Dipropionate

Supelco

PHR1399

Betamethasone Dipropionate

Y0002028

Imidacloprid

Sigma-Aldrich

I6758

IPTG

grau

pharmaceutical primary standard

família API

betamethasone

fabricante/nome comercial

EDQM

aplicação(ões)

pharmaceutical (small molecule)

Formato

neat

temperatura de armazenamento

2-8°C

cadeia de caracteres SMILES

[H][C@@]12C[C@H](C)[C@](OC(=O)CCl)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)C3(F)[C@@]2([H])CCC4=CC(=O)C=C[C@]34C

InChI

1S/C27H34ClFO7/c1-5-22(33)35-14-21(32)27(36-23(34)13-28)15(2)10-19-18-7-6-16-11-17(30)8-9-24(16,3)26(18,29)20(31)12-25(19,27)4/h8-9,11,15,18-20,31H,5-7,10,12-14H2,1-4H3/t15-,18-,19-,20-,24-,25-,26?,27-/m0/s1

chave InChI

UOCNBCVPZWLUKX-HOBFILNXSA-N

Procurando produtos similares? Visita Guia de comparação de produtos

Categorias relacionadas

Padrões de farmacopeias e institutos de metrologia

Descrição geral

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Aplicação

Betamethasone dipropionate for peak identification EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Ações bioquímicas/fisiológicas

Betamethasone 17,21-dipropionate is a glucocorticoid with anti-inflammatory and immunosuppressive activity.

Embalagem

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Outras notas

Sales restrictions may apply.

produto relacionado

Nº do produto

Descrição

Preços

Palavra indicadora

Danger

Frases de perigo

H360FD,H373

Declarações de precaução

P202 - P260 - P280 - P308 + P313 - P405 - P501

Classificações de perigo

Repr. 1B - STOT RE 2

Órgãos-alvo

Liver,Kidney,Endocrine system

Código de classe de armazenamento

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

Classe de risco de água (WGK)

WGK 2

Ponto de fulgor (°F)

Not applicable

Ponto de fulgor (°C)

Not applicable

Escolha uma das versões mais recentes:

Certificados de análise (COA)

Lot/Batch Number

Lamentamos, não temos COA para este produto disponíveis online no momento.

Se precisar de ajuda, entre em contato Atendimento ao cliente

Já possui este produto?

Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.

Visite a Biblioteca de Documentos

Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris of the trunk, limbs and scalp.

Paul L McCormack

Drugs, 71(6), 709-730 (2011-04-21)

Calcipotriol/betamethasone dipropionate (calcipotriol 50 μg/g and betamethasone 0.5 mg/g) is a fixed-dose combination of a vitamin D(3) analogue and a corticosteroid indicated for the once-daily, topical treatment of psoriasis vulgaris of the trunk, limbs and scalp in adults. Both the ointment (Daivobet®;

The effectiveness of two-compound formulation calcipotriol and betamethasone dipropionate gel in the treatment of moderately severe scalp psoriasis: a systematic review of direct and indirect evidence.

Julia M Bottomley et al.

Current medical research and opinion, 27(1), 251-268 (2010-12-15)

To evaluate the two-compound formulation (TCF) calcipotriol and betamethasone dipropionate (BDP) gel versus other topical therapies for scalp psoriasis in adults using direct and indirect comparisons. A systematic review identified 10 randomised controlled trials (RCTs) of topical treatments used in

[The calcipotriol-betamethasone dipropionate association].

F Henry et al.

Revue medicale de Liege, 60(11), 893-895 (2006-01-13)

The topical treatment of psoriasis benefits from the alternate use of dermocorticosteroids and vitamin D3 analogues. A new galenic formulation allows to combine them in a single application. Dovobet (LEO Pharma) ointment is the association of calcipotriol 50 microg/g with

[Calcipotriol plus betamethasone dipropionate gel in the treatment of scalp psoriasis. A review].

M A Radtke et al.

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 61(9), 770-775 (2010-07-21)

Scalp psoriasis has a significant psychosocial impact on individuals affecting their quality of life. It occurs in 50-80% of patients with psoriasis and may be the only affected area of the body. Current topical therapies for scalp psoriasis are difficult

Cost effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate gel in the treatment of scalp psoriasis in Scotland.

Andrew G Affleck et al.

Current medical research and opinion, 27(1), 269-284 (2010-12-15)

To compare the cost effectiveness of the two-compound formulation (TCF) calcipotriol plus betamethasone dipropionate gel used first-, second- or third-line to standard topical treatments for moderately severe scalp psoriasis from a Scottish NHS perspective. Treatment pathways for scalp psoriasis patients

Exibir todos os documentos relacionados

Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.

Entre em contato com a assistência técnica